A Phase II Randomized, Double-Blind, Placebo Controlled, Parallel Study of DCB-BO1202 for Alleviating Liver Fibrosis in HBV Patients With Intermediate Hepatocellular Carcinoma Receiving Loco-regional Therapies
The purpose of this study is to determine whether an investigational drug DCB-BO1202 is effective and safe in the treatment of liver fibrosis in HBV patients having experienced intermediate stage hepatocellular carcinoma (HCC)
100 项与 DCB-BO-1202 相关的临床结果
100 项与 DCB-BO-1202 相关的转化医学
100 项与 DCB-BO-1202 相关的专利(医药)
100 项与 DCB-BO-1202 相关的药物交易